Reckitt Benckiser Group/£RKT

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Reckitt Benckiser Group

Reckitt Benckiser Group is a British multinational consumer goods company headquartered in Slough, England. It operates within the health, hygiene, and home product categories. The company's key brands include Dettol, Lysol, Durex, and Nurofen, offering a wide range of products from disinfectants to pharmaceuticals. Founded in 1999 through the merger of Reckitt & Colman and Benckiser, the company has a significant global presence, with operations in over 60 countries. Reckitt Benckiser's strategic strength lies in its diversified product portfolio and strong brand recognition, which facilitate its competitive positioning in various consumer markets.

Ticker

£RKT

Primary listing

LSE

Industry

Household Products

Employees

37,900

RKT Metrics

BasicAdvanced
£38B
30.87
£1.80
0.10
£2.02
3.63%

What the Analysts think about RKT

Analyst ratings (Buy, Hold, Sell) for Reckitt Benckiser Group stock.

Bulls say / Bears say

Reckitt's business in China is thriving, experiencing double-digit sales growth annually, driven by strong performance of products like Dettol disinfectants. (reuters.com)
The company reported a 3.2% increase in like-for-like sales in its Health segment during Q3 2024, surpassing analyst expectations. (smartkarma.com)
Reckitt's strategic focus on high-growth markets and premiumization, alongside cost optimization efforts, positions it well for future growth. (simplywall.st)
Reckitt missed its fourth-quarter sales expectations, with like-for-like net sales increasing by 4.6%, falling short of the expected 5.3%. (reuters.com)
The company's plan to sell its household cleaning product portfolio, including Air Wick, is facing potential collapse due to ongoing market volatility. (ft.com)
Reckitt's first-quarter like-for-like net sales grew by 1.1%, missing analysts’ expectations of 1.4%, attributed to declining sales volumes in key markets. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.

RKT Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RKT Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £RKT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Aug7
Reckitt Benckiser Group
Dividend·Ex-dividend
Sept18
Reckitt Benckiser Group
Dividend·Payment
£0.844Per share
FAQs